title: [Cystic Fibrosis: toward a genetic treatment; Clostridium difficile versus Clostridium difficile].
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Nau
mesh_terms: D000627:Aminophenols / Q000627:therapeutic use*; D000631:Aminopyridines / Q000627:therapeutic use*; D052117:Benzodioxoles / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D016360:Clostridioides difficile / Q000472:pathogenicity*; D003015:Clostridium Infections / Q000382:microbiology / Q000628:therapy*; D003550:Cystic Fibrosis / Q000097:blood / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000819:agonists* / Q000235:genetics; D004359:Drug Therapy, Combination; D006801:Humans; D009154:Mutation; D015363:Quinolones / Q000627:therapeutic use*; D013171:Spores, Bacterial; D016896:Treatment Outcome
chemical_list: D000627:Aminophenols; D000631:Aminopyridines; D052117:Benzodioxoles; D015415:Biomarkers; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor; C569105:lumacaftor